Lab Testing

Extract the most value out of our globally integrated central laboratory network with the help of our scientific and operational experts.

Ensure specimen safety and integrity in our purpose-built biorepository backed by fully redundant power supplies and auditable tracking systems throughout the chain of custody.

Seamlessly combine codified informed consent with specimen, clinical and biomarker data using specimen lifecycle management service to further accelerate drug development programs.

Use best-in-class customized, bar-coded, visit-specific specimen collection kits with the confidence they’ll be delivered on time to investigator sites. And rely on our globally located team of more than 50 logistics experts for contingency plans that help assure on-time and in-stability shipments.

View individual test results, monitor trends, track sample shipments, confirm site communications, order kits and access version-controlled laboratory manuals—all through the accelerate Lab portals.

Browse combined data across one study or multiple studies with live specimen data using specimen lifecycle management service. View sample reconciliation and codified consent management. Proactively address risks by managing patient enrollment and implementing risk-based monitoring strategies.

Take on complex biomarker and advanced cytometric challenges through an extensive flow cytometry offering, spanning complex/translational biomarkers, mass cytometry, and use at clinical trial scale for primary, secondary or experimental endpoints.

Guide your decision-making from discovery to the clinic with exploratory biomarker insights from our Translational Biomarker Solutions (TBS). From initial feasibility and development to advanced validation, testing and production, the experienced TBS team offers collaborative support and fit-for-purpose assays using a diverse toolbox of platforms. Personalized biomarker support is also available to help drive your development from bench to commercialization.

Quality laboratory management made easy. ELMS manages third-party laboratory performance with a rigorous identification, qualification, monitoring and reporting plan to ensure high quality and actionable data. The ELMS team will also support esoteric testing through LabCorp’s Specialty Testing Group, a distinctive combination of specialty laboratories offering discrete esoteric testing capabilities and expertise.

APH laboratories located strategically around the world—many co-located within our global network of central labs—employ innovative technologies, such as digital pathology or multiplex IHC to unlock and analyze scientific insights.

Digital Pathology at our Laboratories reflects a holistic approach to innovating anatomic pathology for the modern needs of global clinical trials. It is built on globally harmonized, state-of-the-art histopathology practices and our proprietary host platform for image data called MIRA (Medical Image Review and Analysis). Integrated with our global LIMS, the beginning-to-end offering is a seamless Digital Pathology solution created to optimise global central pathology review in support of today’s elaborate clinical trial designs.

Measure and follow biomarkers, hormones, specific antibodies or viral markers in urine, serum or plasma to gain insights to patient response to therapeutic interventions. We offer a specialized, dedicated vaccine team and a purpose-built vaccines and novel immunotherapeutics laboratory to deliver support for vaccine development – from biomarker discovery and assay development to clinical testing in seasonal or multi-year global studies.

As you advance your molecule through the drug development continuum, you’ll need quality data to make well-informed decisions. As your partner, we work to develop the most efficient and accurate methods, removing barriers and speeding your development timeline. And, given the time pressures we all face, our high-throughput and globally transferable methods enable you to make decisions faster.

Your drug development programs need regulatory approval to move on to the next milestone. Our scientists aren’t just familiar with the regulatory process; they are active contributors to key regulatory discussions. With leadership roles in the Global Bioanalytical Consortium, our scientists participate to help shape today’s changing regulatory environment. We have the regulatory expertise you need and will help you ask the right questions to keep your program on track. Specific knowledge of the latest bioanalytical platforms such as AB Sciex, Waters®, Hamilton Star®, Watson Plus™, Gyros™, BioPlex®, MSD and ELISA help inform your molecule’s development as we partner with you to generate high-quality results.

Providing you with key insights more quickly enables you to make informed decisions faster. When you integrate our bioanalysis services with our market-leading Central Laboratory Services, you’ll increase data delivery speed by up to 50%, reduce sample demographic discrepancies and eliminate lab-to-lab shipment fees.